 |
인쇄하기
취소
|
Testing of new combination drug approved by KFDA
Ildong Pharmaceutical said Wednesday it has received approval from the Korea Food and Drug Administration to conduct clinical trials of a combination drug for the treatment of hypertension and hyperlipidemia.
The drug is a single-pill combination of telmisartan and rosuvastatin.
“The new combination drug is especially designed for better patient compliance,” said a company official.
On...
The drug is a single-pill combination of telmisartan and rosuvastatin.
“The new combination drug is especially designed for better patient compliance,” said a company official.
On...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.